FDA's Approval of New Cannabis-Derived Drug Will Pave the Way for Future Medications, CEO Says

Cannabis Business Times
Jun 27, 2018, 8:40 am8 pts
Justin Gover, the CEO of GW Pharmaceuticals, told CNBC his company's new drug will pave the way for other medications derived from marijuana. On Monday, the Food and Drug Administration approved the company's new epilepsy drug, Epidiolex, the first cannabis-based drug the U.S. regulator has approved. "This is…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Calif. regulator departs a market in turmoil 76

Missouri Marijuana Microbusinesses Begin First Crop Harvests Amid Struggle To Succeed 74

Texas Officials Post Hemp Law ‘Checklist’ List To Help Businesses Comply With State Cannabis Rules 73

Arkansas medical marijuana sales continue at record pace 70

‘They’re lying’: deal to reopen government could doom hemp 69

Flavor Fix Launches “Pair’d” — A New Platform for Discovering Cannabis, Cuisine, and Cocktail Pairings 64

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.